GMVIX
Price
$17.14
Change
+$0.08 (+0.47%)
Updated
Jan 17 closing price
Net Assets
153.82M
VIMAX
Price
$339.07
Change
+$1.71 (+0.51%)
Updated
Jan 17 closing price
Net Assets
176.87B
Ad is loading...

GMVIX vs VIMAX

Header iconGMVIX vs VIMAX Comparison
Open Charts GMVIX vs VIMAXBanner chart's image
Goldman Sachs Small/Mid Cap Value I
Price$17.14
Change+$0.08 (+0.47%)
VolumeN/A
Net Assets153.82M
Vanguard Mid Cap Index Admiral
Price$339.07
Change+$1.71 (+0.51%)
VolumeN/A
Net Assets176.87B
GMVIX vs VIMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
GMVIX vs. VIMAX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GMVIX is a Hold and VIMAX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
VIMAX has more cash in the bank: 177B vs. GMVIX (154M). VIMAX pays higher dividends than GMVIX: VIMAX (1.49) vs GMVIX (0.76). GMVIX was incepted earlier than VIMAX: GMVIX (11 years) vs VIMAX (23 years). GMVIX is a more actively managed with annual turnover of: 56.00 vs. VIMAX (13.00). GMVIX has a lower initial minimum investment than VIMAX: GMVIX (0) vs VIMAX (3000). VIMAX annual gain was more profitable for investors over the last year : 20.83 vs. GMVIX (17.44). VIMAX return over 5 years is better than : 50.72 vs. GMVIX (32.13).
GMVIXVIMAXGMVIX / VIMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence11 years23 years-
Gain YTD3.8163.732102%
Front LoadN/AN/A-
Min. Initial Investment03000-
Min. Initial Investment IRAN/AN/A-
Net Assets154M177B0%
Annual Yield % from dividends0.761.4951%
Returns for 1 year17.4420.8384%
Returns for 3 years2.3315.3115%
Returns for 5 years32.1350.7263%
Returns for 10 years70.84130.4354%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DNA10.830.63
+6.18%
Ginkgo Bioworks Holdings
SKLZ6.260.17
+2.79%
Skillz
RXRX6.530.13
+2.03%
Recursion Pharmaceuticals
AVGR0.600.01
+1.71%
Avinger
EMN93.211.47
+1.60%
Eastman Chemical Company